Results 71 to 80 of about 17,943 (173)
Background: Rocuronium bromide is a new amino steroidal neuromuscular blocking agent which is structurally related to vecuronium and its onset time and intubating conditions are comparable with succinylcholine and without the undesirable side effects.
Pratibha Bhunia +3 more
doaj +1 more source
Background and Aims: Patients with intracranial tumour are usually on anticonvulsants. Patients on phenytoin therapy demonstrate rapid metabolism of nondepolarising muscle relaxants secondary to enzyme induction.
Veena Sheshadri +3 more
doaj +1 more source
Hui Chen,* Jing-Qiu Wei,* Yi-Wen Wang, Kun-Peng Zhou, Ying He, He Liu, Yue-Ying Zhang Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221004, People’s Republic of China*These authors contributed ...
Chen H +6 more
doaj
The effect of palonosetron on rocuronium-induced withdrawal movement
Background: Rocuronium causes pain and withdrawal movement during induction of anesthesia. In this study, palonosetron was investigated to have analgesic effect on the reduction of rocuronium-induced withdrawal movement.
Ki-Bum Park +5 more
doaj +1 more source
Rocuronium for Caesarean section
W F, Kwan, B J, Chen, K T, Liao
openaire +4 more sources
This study was designed to compare the variability of the onset and offset of the effect of two neuromuscular blocking drugs with different elimination pathways in adult and elderly patients during total intravenous anesthesia (TIVA).
Feng Xiaobo, Ke Jianjuan, Wang Yanlin
doaj +2 more sources
Background: Rocuronium injection pain is a common side effect during anesthesia induction, causing patient dissatisfaction and rocuronium injection withdrawal movement, putting the patient at risk for serious complications.
Nazanin Hasannejad +4 more
doaj +1 more source
Accelerated onset of rocuronium [PDF]
openaire +2 more sources
Malicious poisoning of a canine with the neuromuscular blocking agent rocuronium: a case report with postmortem quantitation. [PDF]
Buchweitz JP +3 more
europepmc +1 more source

